{"SPADE_UN_14151": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_14151", "Peptide Name": "Temporin L[Pro3,DLeu9,DLys10](TL9)", "Source": "Synthetic construct(derived from Temporin-L)", "Family": "Coronaviridae, Herpesviridae, Paramyxoviridae", "Gene": "Not found", "Sequence": "FVPWFSKFLKRIL", "Sequence Length": 13, "UniProt Entry": "No entry found", "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Antiviral"], "Target Organism": "[Ref.35216177]HSV-1:inhibition of HSV-1 replication in Vero cells(IC50=3.53 μM,IC90=12.71 μM);HSV-2:inhibition of HSV-2 replication in Vero cells(IC50=2.80 μM μM,IC90=12.50 μM);SARS-CoV-2:inhibition of  replication in Vero cells(IC50=4.63 μM μM,IC90=25.33 μM);HPIV-3:inhibition of replication in Vero cells(IC50=40.64 μM,IC90>50.00 μM);HCoV-229E:inhibition of replication in Vero cells(IC50=5.39 μM,IC90=50.00 μM);HCoV-OC43:inhibition of replication in Vero cells(IC50=8.29 μM,IC90=29.17 μM).", "Hemolytic Activity": "[Ref.35216177]<20% hemolysis against human erythrocytes at concentrations equal or above 25 μM.", "Cytotoxicity": "[Ref.35216177]Vero cells:CC50= 45.92 μM", "Binding Target": "membrane", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "Mixed(D-Leu9,D-Lys10)", "Structure Description": "Not found", "Formula": "C75H102N16O11", "Mass": 1681.07, "PI": 11.17, "Net Charge": 3, "Hydrophobicity": 0.7, "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min", "Mechanism of action": "TL peptides may be able to selectively induce pore formation in highly curved membrane structures (below ~250 nm in diameter), resulting in membrane lysis once a critical number of pores is formed, with the consequence of viral infectivity reduction.", "Literature": [{"Title": "Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs.", "Pubmed ID": "35216177", "Reference": "Int J Mol Sci. 2022 Feb 13;23(4)2060.", "Author": "Zannella C, Chianese A, Palomba L, Marcocci ME, Bellavita R, Merlino F, Grieco P, Folliero V, De Filippis A, Mangoni M, Nencioni L, Franci G, Galdiero M.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=35216177"}], "Frequent Amino Acids": "FKL", "Absent Amino Acids": "ACDEGHMNOQTUY", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 5, "Positive Residues": 3, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_14148", "Similarity": 1.0, "Sequence": "FVPWFSKFLRIL"}, {"SPADE_ID": "SPADE_UN_14149", "Similarity": 1.0, "Sequence": "FVPWFSKFLRIL"}, {"SPADE_ID": "SPADE_UN_14150", "Similarity": 1.0, "Sequence": "FVPWFSKFLKRIL"}]}}}